Susquehanna International Group, LLP Dia Medica Therapeutics Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 374,845 shares of DMAC stock, worth $2.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
374,845
Previous 101,450
269.49%
Holding current value
$2.34 Million
Previous $425,000
366.35%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DMAC
# of Institutions
49Shares Held
5.18MCall Options Held
8.2KPut Options Held
200-
Vanguard Group Inc Valley Forge, PA1.24MShares$7.74 Million0.0% of portfolio
-
First Manhattan CO New York, NY839KShares$5.23 Million0.01% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX515KShares$3.21 Million6.41% of portfolio
-
Bleichroeder LP New York, NY382KShares$2.38 Million0.63% of portfolio
-
Geode Capital Management, LLC Boston, MA306KShares$1.9 Million0.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $165M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...